Science and Discovery

Ai Drug Discovery

2 articles

Editorial illustration for Inside Stanford's Virtual Biotech: 37,000 AI Agents and the Three Discovery Tasks They Performed
Health & Medicine

Inside Stanford's Virtual Biotech: 37,000 AI Agents and the Three Discovery Tasks They Performed

Stanford Medicine researchers have developed a "virtual biotech" company composed of 37,000 AI agents, demonstrating its capability to perform three critical early-stage drug discovery tasks: target prioritization, cancer target validation, and analysis of failed clinical trials.

Marcus Cole·October 27, 2026
Holographic molecular models and AI interfaces in a futuristic lab, representing accelerated drug discovery and in silico trials.
Technology & AI

AI Drug Development Market Surges as In Silico Trials Promise Major Efficiency Gains

The AI drug development market is experiencing dramatic growth, with in silico trials poised to significantly reduce research timelines and costs. While investment and data availability fuel this expansion, challenges in data integration and regulatory frameworks persist.

Aram Sarkisian·June 6, 2026